SPL 0.54% 9.4¢ starpharma holdings limited

ASCO Presentations 2024, page-9

  1. 1,801 Posts.
    lightbulb Created with Sketch. 322
    I would hope that the results of cabazitaxel and irinotecan are being used at the conference to showcase the company's technology and promote new partnerships…for DEP Gemcitabine for example.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
0.001(0.54%)
Mkt cap ! $38.81M
Open High Low Value Volume
9.4¢ 9.4¢ 9.3¢ $18.55K 199.4K

Buyers (Bids)

No. Vol. Price($)
3 360670 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 57000 3
View Market Depth
Last trade - 12.40pm 13/09/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.